sulfasalazine has been researched along with Alopecia Circumscripta in 6 studies
Sulfasalazine: A drug that is used in the management of inflammatory bowel diseases. Its activity is generally considered to lie in its metabolic breakdown product, 5-aminosalicylic acid (see MESALAMINE) released in the colon. (From Martindale, The Extra Pharmacopoeia, 30th ed, p907)
sulfasalazine : An azobenzene consisting of diphenyldiazene having a carboxy substituent at the 4-position, a hydroxy substituent at the 3-position and a 2-pyridylaminosulphonyl substituent at the 4'-position.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Thirty-nine patients with persistent alopecia areata received 3 g of oral sulfasalazine for 6 months, and terminal hair regrowth was quantified as no response, moderate response, or good response." | 9.13 | Treatment of persistent alopecia areata with sulfasalazine. ( Mahd, AA; Rashidi, T, 2008) |
| "Promising results have been published in the past with the use of sulfasalazine in alopecia areata." | 7.74 | Is there a role for sulfasalazine in the treatment of alopecia areata? ( Bakar, O; Gurbuz, O, 2007) |
| "Thirty-nine patients with persistent alopecia areata received 3 g of oral sulfasalazine for 6 months, and terminal hair regrowth was quantified as no response, moderate response, or good response." | 5.13 | Treatment of persistent alopecia areata with sulfasalazine. ( Mahd, AA; Rashidi, T, 2008) |
| "Promising results have been published in the past with the use of sulfasalazine in alopecia areata." | 3.74 | Is there a role for sulfasalazine in the treatment of alopecia areata? ( Bakar, O; Gurbuz, O, 2007) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (16.67) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (66.67) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Rashidi, T | 1 |
| Mahd, AA | 1 |
| Alkhalifah, A | 1 |
| Alsantali, A | 1 |
| Wang, E | 1 |
| McElwee, KJ | 1 |
| Shapiro, J | 1 |
| Misery, L | 1 |
| Sannier, K | 1 |
| Chastaing, M | 1 |
| Le Gallic, G | 1 |
| Bakar, O | 1 |
| Gurbuz, O | 1 |
| Ellis, CN | 1 |
| Brown, MF | 1 |
| Voorhees, JJ | 1 |
| Thompson, DM | 1 |
| Robinson, TW | 1 |
| Lennard-Jones, J | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Efficacy of Combined CO2 Fractional Laser With Bimatoprost 0.03% in Treatment of Alopecia Areata[NCT05600673] | Phase 1/Phase 2 | 30 participants (Actual) | Interventional | 2019-01-01 | Completed | ||
| Efficacy of Fractional CO2 Laser Alone and as Transepidermal Drug Delivery for Different Modalities of Treatment in Alopecia Areata[NCT04003376] | Phase 4 | 40 participants (Anticipated) | Interventional | 2019-07-26 | Recruiting | ||
| Effectiveness and Safety of Tofacitinib in Patients With Extensive and Recalcitrant Alopecia Areata[NCT03800979] | Phase 4 | 19 participants (Actual) | Interventional | 2019-01-12 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
Patients came back for follow-up every month during a total of 24 weeks of treatments and at weeks 28,36 and 48. (NCT03800979)
Timeframe: 48 weeks
| Intervention | participants (Number) | ||||||
|---|---|---|---|---|---|---|---|
| Dyslipidemia | Upper respiratory tract infection | Tuberculosis | Myalgia | Acne | Weight gain | Constipation | |
| Tofacitinib | 9 | 6 | 1 | 1 | 2 | 1 | 1 |
1 review available for sulfasalazine and Alopecia Circumscripta
| Article | Year |
|---|---|
Alopecia areata update: part II. Treatment.
Topics: Administration, Topical; Adrenal Cortex Hormones; Adult; Alopecia Areata; Animals; Child; Cyclopropa | 2010 |
Alopecia areata update: part II. Treatment.
Topics: Administration, Topical; Adrenal Cortex Hormones; Adult; Alopecia Areata; Animals; Child; Cyclopropa | 2010 |
Alopecia areata update: part II. Treatment.
Topics: Administration, Topical; Adrenal Cortex Hormones; Adult; Alopecia Areata; Animals; Child; Cyclopropa | 2010 |
Alopecia areata update: part II. Treatment.
Topics: Administration, Topical; Adrenal Cortex Hormones; Adult; Alopecia Areata; Animals; Child; Cyclopropa | 2010 |
Alopecia areata update: part II. Treatment.
Topics: Administration, Topical; Adrenal Cortex Hormones; Adult; Alopecia Areata; Animals; Child; Cyclopropa | 2010 |
Alopecia areata update: part II. Treatment.
Topics: Administration, Topical; Adrenal Cortex Hormones; Adult; Alopecia Areata; Animals; Child; Cyclopropa | 2010 |
Alopecia areata update: part II. Treatment.
Topics: Administration, Topical; Adrenal Cortex Hormones; Adult; Alopecia Areata; Animals; Child; Cyclopropa | 2010 |
Alopecia areata update: part II. Treatment.
Topics: Administration, Topical; Adrenal Cortex Hormones; Adult; Alopecia Areata; Animals; Child; Cyclopropa | 2010 |
Alopecia areata update: part II. Treatment.
Topics: Administration, Topical; Adrenal Cortex Hormones; Adult; Alopecia Areata; Animals; Child; Cyclopropa | 2010 |
1 trial available for sulfasalazine and Alopecia Circumscripta
| Article | Year |
|---|---|
Treatment of persistent alopecia areata with sulfasalazine.
Topics: Administration, Oral; Adolescent; Adult; Alopecia Areata; Dose-Response Relationship, Drug; Drug Adm | 2008 |
4 other studies available for sulfasalazine and Alopecia Circumscripta
| Article | Year |
|---|---|
Treatment of alopecia areata with sulfasalazine.
Topics: Adult; Alopecia Areata; Anti-Inflammatory Agents, Non-Steroidal; Eyelashes; Hair; Humans; Immunosupp | 2007 |
Is there a role for sulfasalazine in the treatment of alopecia areata?
Topics: Adolescent; Adult; Alopecia Areata; Anti-Inflammatory Agents, Non-Steroidal; Female; Humans; Middle | 2007 |
Sulfasalazine for alopecia areata.
Topics: Adolescent; Adult; Alopecia Areata; Diseases in Twins; Female; Humans; Immunosuppressive Agents; Mid | 2002 |
Alopecia areata, vitiligo, scleroderma and ulcerative colitis.
Topics: Adult; Alopecia Areata; Barium Sulfate; Colitis, Ulcerative; Enema; Humans; Lichen Planus; Male; Pre | 1974 |